Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nutriband Inc WT (NQ: NTRBW )

0.3000 -0.1800 (-37.50%)
Streaming Delayed Price Updated: 3:38 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 36,690
Open 0.3500
Bid (Size) 0.0002 (500)
Ask (Size) 1.480 (16)
Prev. Close 0.4800
Today's Range 0.3000 - 0.3500
52wk Range 0.1963 - 3.840
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling
Via ACCESSWIRE
Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape
Via ACCESSWIRE

Performance

YTD
-88.00%
-88.00%
1 Month
N/A
N/A
3 Month
-57.14%
-57.14%
6 Month
-84.46%
-84.46%
1 Year
-90.00%
-90.00%

More News

Read More
Nutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales 0f $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm
Via ACCESSWIRE
Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications
Via Get News
Topics Intellectual Property
Exposures Intellectual Property
Nutriband Unveils Groundbreaking Innovation in Transdermal Medications
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
Via ACCESSWIRE
Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023
Via ACCESSWIRE
Nutriband Unveils Groundbreaking Innovation in Transdermal Medications
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
Via FinancialNewsMedia
Topics Death Intellectual Property
Exposures Death Intellectual Property
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
Via FinancialNewsMedia
Topics Intellectual Property
Exposures Intellectual Property
Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador
Via ACCESSWIRE
Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission
Via ACCESSWIRE
Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
Via ACCESSWIRE
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
Via ACCESSWIRE
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology
Via ACCESSWIRE
Nutriband to Attend 2023 BIO International Convention
Via ACCESSWIRE
Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023
Via ACCESSWIRE
Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023
Via ACCESSWIRE
Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development
Via ACCESSWIRE
Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology
Via ACCESSWIRE
Nutriband Inc Joins Webull Corporate Communications Service Platform
Via ACCESSWIRE
Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee
Via ACCESSWIRE
Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.